Immuno-related adverse events from check-point inhibitors during immune-therapy for cancer. Imaging findings. (March 2018) - Sandomenico, F.; De rosa, G.; Pizza, S.; Catalano, O.; Setola, S.; Simeone, E.; Festino, L.; Grimaldi, A.; Vanella, V.; Petrillo, A.; Ascierto, P.